Natriuretic Peptides
-
Subject Areas on Research
- A Test in Context: Critical Evaluation of Natriuretic Peptide Testing in Heart Failure.
- Biomarker guided therapy for heart failure: focus on natriuretic peptides.
- Biomarkers in Pulmonary Vascular Disease: Gauging Response to Therapy.
- Biomarkers in acutely decompensated heart failure with preserved or reduced ejection fraction.
- Cardiac natriuretic peptides, obesity, and insulin resistance: evidence from two community-based studies.
- Clinical profile and prognostic value of anemia at the time of admission and discharge among patients hospitalized for heart failure with reduced ejection fraction: findings from the EVEREST trial.
- GUCY2C Signaling Opposes the Acute Radiation-Induced GI Syndrome.
- Haemoconcentration, renal function, and post-discharge outcomes among patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial.
- Hemoconcentration-guided diuresis in heart failure.
- Influence of sex and hormone status on circulating natriuretic peptides.
- Natriuretic Peptide-guided therapy for heart failure.
- Natriuretic Peptides in Older Patients With Heart Failure: A Look Into the Seeds of Time.
- Obesity-Induced Colorectal Cancer Is Driven by Caloric Silencing of the Guanylin-GUCY2C Paracrine Signaling Axis.
- Patient selection in heart failure with preserved ejection fraction clinical trials.
- Predictors of early dyspnoea relief in acute heart failure and the association with 30-day outcomes: findings from ASCEND-HF.
- Purification, cDNA sequence, and tissue distribution of rat uroguanylin.
- Relation of serum uric acid levels and outcomes among patients hospitalized for worsening heart failure with reduced ejection fraction (from the efficacy of vasopressin antagonism in heart failure outcome study with tolvaptan trial).
- Relation of visceral adiposity to circulating natriuretic peptides in ambulatory individuals.
- Targeting Natriuretic Peptide Levels in Heart Failure with Therapy: Does "X" Really Mark the Spot?
- The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries.
- The paracrine hormone for the GUCY2C tumor suppressor, guanylin, is universally lost in colorectal cancer.
- The potential role of natriuretic peptide-guided management for patients hospitalized for heart failure.
- Therapeutic implications of biomarkers in chronic heart failure.
- Using Natriuretic Peptides for Selection of Patients in Acute Heart Failure Clinical Trials.
-
Keywords of People
- O'Connor, Christopher Michael, Richard Sean Stack, M.D. Distinguished Professor, Medicine, Clinical Pharmacology